|
|
| | CCT196969 Basic information |
| Product Name: | CCT196969 | | Synonyms: | CCT196969;1-(3-(tert-Butyl)-1-phenyl-1H-pyrazol-5-yl)-3-(2-fluoro-4-((3-oxo-3,4-dihydropyrido[2,3-b]pyra;CCT196969; CCT-196969; CCT 196969;CS-2447;Urea, N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-fluorophenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]-;CCT 196969,Raf,CCT196969,CCT-196969,Inhibitor,inhibit,Raf kinases | | CAS: | 1163719-56-9 | | MF: | C27H24FN7O3 | | MW: | 513.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1163719-56-9.mol |  |
| | CCT196969 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: Soluble | | form | A solid | | color | White to off-white |
| | CCT196969 Usage And Synthesis |
| Uses | CCT196969 is a paradox-breaking RAF inhibitor that also targets SRC and is thus effective in drug-resistant BRAF mutant melanoma. |
| | CCT196969 Preparation Products And Raw materials |
|